RebrandingMay 29, 2026, 07:36 AM
EDAP TMS SA Rebrands to FocalTherics, Ticker FOCL; Discontinues Legacy Segments
AI Summary
EDAP TMS S.A. announced it will begin operating under the new corporate name "FocalTherics" and trade under the new Nasdaq ticker symbol "FOCL" starting June 1, 2026. This rebranding reflects the company's exclusive focus on high-growth robotic focal therapy. Additionally, EDAP intends to classify its legacy Extracorporeal Shock Wave Lithotripsy (ESWL) and Distribution operating segments as discontinued operations, beginning with its second quarter 2026 financial results. The company will discuss its new identity and strategy at an Investor Day on June 1, 2026.
Key Highlights
- Company to operate under new corporate name "FocalTherics".
- New Nasdaq ticker symbol "FOCL" effective at market open on June 1, 2026.
- ESWL and Distribution operating segments to be classified as discontinued operations from Q2 2026.
- Legal name EDAP TMS S.A. remains, with future shareholder approval sought for change.
- Investor Day on June 1, 2026, to discuss new corporate identity, growth strategy, and business outlook.
Price Impact
More from EDAP